Generalized linear mixed effects models were used to compare the low carnitine status with normal carnitine group in patient measures of body mass index, seizure frequency and severity, number of anti-seizure medications, beta-hydroxybutyrate, triglyceride, and carnitine levels across baseline, 39-month follow-up (timepoint 1), 1-2-year follow-up (timepoint 2), and 2+ year follow-up (timepoint 3)
HOMA2-IR returns in proportion to regain (about +0.6% at under-25% regain to +39.5% at 50-75%)
L-Lysine is generally considered highly safe and well-tolerated, even at therapeutic doses
By starting smaller, the program aims to help support weight loss while making the experience feel more manageable, more affordable, and potentially easier on your body
a probiotic to support the microbiome and healthy digestion
Data were derived from de-identified electronic health record (EHR) extracts including medication orders, patient demographics, and longitudinal weight measurements